DNJ upholds Abilify patent
DNJ on Monday, Nov. 15 upheld the Abilify patent of Otsuka Pharmaceutical Co. Ltd.
posted by Lawrence B. Ebert at 7:05 PM
Wednesday, November 17, 2010
About Me
- Name: Lawrence B. Ebert
I'm a patent lawyer located in central New Jersey. I have a J.D. from the University of Chicago and a Ph.D. from Stanford University, where I studied graphite intercalation compounds at the Center for Materials Research. I worked at Exxon Corporate Research in areas ranging from engine deposits through coal and petroleum to fullerenes. An article that I wrote in The Trademark Reporter, 1994, 84, 379-407 on color trademarks was cited by Supreme Court in Qualitex v. Jacobson, 514 US 159 (1995) and the methodology was adopted in the Capri case in N.D. Ill. An article that I wrote on DNA profiling was cited by the Colorado Supreme Court (Shreck case) and a Florida appellate court (Brim case). I was interviewed by NHK-TV about the Jan-Hendrik Schon affair. I am developing ipABC, an entity that combines rigorous IP analytics with study of business models, to optimize utilization of intellectual property. I can be reached at C8AsF5 at yahoo.com.
Previous Posts
- Is intent needed to establish plagiarism?
- NCIS does Gatling guns on 16 Nov 2010
- Forbes names HP for one of year's biggest blunders
- New York City cracks down on bed bugs: disposed m...
- Hawaii Five-O continues Jersey jokes
- University of New Mexico sues Intel over US 6.042.998
- The Scientist discusses two science fraud cases
- Dicta in Aukai case in 2007 hits home in Tyner "gr...
- CAFC Abbyy case on service of process
- Microsoft's US 7,830,359, Foot-based interface for...
0 Comments:
Post a Comment
<< Home